Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33762245

MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
BMJ Open
Publication date
2021 Mar 24
First author
Brown S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Brown S
      type
      Author
    2. name
      Sherratt D
      type
      Author
    3. name
      Hinsley S
      type
      Author
    4. name
      Flanagan L
      type
      Author
    5. name
      Roberts S
      type
      Author
    6. name
      Walker K
      type
      Author
    7. name
      Hall A
      type
      Author
    8. name
      Pratt G
      type
      Author
    9. name
      Messiou C
      type
      Author
    10. name
      Jenner M
      type
      Author
    11. name
      Kaiser M
      type
      Author
    12. name
      Myeloma UK Early Phase Clinical Trial Network
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Brown S
      type
      Author
    2. name
      Sherratt D
      type
      Author
    3. name
      Hinsley S
      type
      Author
    4. name
      Flanagan L
      type
      Author
    5. name
      Roberts S
      type
      Author
    6. name
      Walker K
      type
      Author
    7. name
      Hall A
      type
      Author
    8. name
      Pratt G
      type
      Author
    9. name
      Messiou C
      type
      Author
    10. name
      Jenner M
      type
      Author
    11. name
      Kaiser M
      type
      Author
    12. name
      Myeloma UK Early Phase Clinical Trial Network
      type
      CollectiveName
    bibliography ids
    1. nci-bib-970a410d49234a1fd1c021e9
    book metadata
    content sha256
    7483864a19d97ea82f590376a6f7cedd79eabd17ecf9ff23baa7d5a2ec5804ff
    document type
    citation
    dois
    1. 10.1136/bmjopen-2020-046225
    electronic publication date
    display
    2021 Mar 24
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33762245
    immutable id
    pubmed:33762245@7483864a19d97ea82f590376a6f7cedd79eabd17ecf9ff23baa7d5a2ec5804ff
    journal
    abbreviation
    BMJ Open
    issn electronic
    2044-6055
    issn print
    Source null
    issue
    3
    name
    BMJ open
    nlm unique id
    101552874
    pages
    e046225
    volume
    11
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33762245
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      1b494689c05cf4deb1e0e35e0a3c00c495116c512d28bfa460967857a3b3d1d2
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Mar 24
      precision
      day
      year
      2021
      publication types
      1. Clinical Trial Protocol
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33762245/
      title
      MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase II study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia.

      Preserved source evidence · Not medical advice